Correlation Between Inozyme Pharma and Lexicon Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Lexicon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Lexicon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Lexicon Pharmaceuticals, you can compare the effects of market volatilities on Inozyme Pharma and Lexicon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Lexicon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Lexicon Pharmaceuticals.
Diversification Opportunities for Inozyme Pharma and Lexicon Pharmaceuticals
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inozyme and Lexicon is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Lexicon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexicon Pharmaceuticals and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Lexicon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexicon Pharmaceuticals has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Lexicon Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Lexicon Pharmaceuticals
Given the investment horizon of 90 days Inozyme Pharma is expected to generate 0.8 times more return on investment than Lexicon Pharmaceuticals. However, Inozyme Pharma is 1.24 times less risky than Lexicon Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Lexicon Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 234.00 in Inozyme Pharma on November 2, 2024 and sell it today you would lose (88.00) from holding Inozyme Pharma or give up 37.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Lexicon Pharmaceuticals
Performance |
| Timeline |
| Inozyme Pharma |
| Lexicon Pharmaceuticals |
Inozyme Pharma and Lexicon Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Lexicon Pharmaceuticals
The main advantage of trading using opposite Inozyme Pharma and Lexicon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Lexicon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexicon Pharmaceuticals will offset losses from the drop in Lexicon Pharmaceuticals' long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Lexicon Pharmaceuticals vs. BioLineRx | Lexicon Pharmaceuticals vs. Ardelyx | Lexicon Pharmaceuticals vs. Seres Therapeutics | Lexicon Pharmaceuticals vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |